One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Clinical Practice Guideline Methodology: An Evolving Science
Kevin C. Wilson
Yet Another Crack in the Facade of the Centers for Medicare and Medicaid Services Hospital Readmissions Reduction Program for Chronic Obstructive Pulmonary Disease
Russell G. Buhr 1,2 and Jerry A. Krishnan 3,4
Adding Insult to Injury: Does COVID-19 Promote Acute Respiratory Distress Syndrome by Inhibiting Surfactant?
Bradley W. Richmond 1,2,3 and Charles S. Dela Cruz 4,5,6
The Promise of Liquid Biopsies: Extracellular Vesicle microRNAs Open the Door to Future Study in Lung Disease
Scott M. Matson and Isaac Kirubakaran Sundar
Risk Stratifying Interstitial Lung Abnormalities to Guide Early Diagnosis of Interstitial Lung Diseases
Marlies S. Wijsenbeek 1 and Guy G. Brusselle 2,3
Criteria for Progressive Pulmonary Fibrosis: Getting the Horse Ready for the Cart
Vincent Cottin 1,2
Expanding the Reach of Lung Cancer Screening: Risk Models for Individuals Who Never Smoked
Anil Vachani 1 and Patrick Nana-Sinkam 2
Seeing Premature Lung Disease: Hyperpolarized Xe Magnetic Resonance Imaging
Erik B. Hysinger and Jason C. Woods
Executive Summary: International Clinical Practice Guidelines for Pediatric Ventilator Liberation, A Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network Document
Samer Abu-Sultaneh 1,2, Narayan Prabhu Iyer 3,4, AnalÃÂa Fernández 5, Michael Gaies 6, Sebastián González-Dambrauskas 7, Justin Christian Hotz 8, Martin C. J. Kneyber 9, Yolanda M. López-Fernández 10, Alexandre T. Rotta 11, David K. Werho 12, Arun Kumar Baranwal 13, Bronagh Blackwood 14, Hannah J. Craven 15, Martha A. Q. Curley 16,17, Sandrine Essouri 18, Jose Roberto Fioretto 19, Silvia M. M. Hartmann 20, Philippe Jouvet 18, Steven Kwasi Korang 8,21, Gerrard F. Rafferty 22, Padmanabhan Ramnarayan 23, Louise Rose 24, Lyvonne N. Tume 25, Elizabeth C. Whipple 15, Judith J. M. Wong 26, Guillaume Emeriaud 18, Christopher W. Mastropietro 1,2, Natalie Napolitano 27, Christopher J. L. Newth 4,8, and Robinder G. Khemani 4,8;
Care Quality for Patients with Chronic Obstructive Pulmonary Disease in the Readmission Penalty Era
Juan C. Rojas 1*, Sukarn Chokkara 1*, Mengqi Zhu 1, Peter K. Lindenauer 2, and Valerie G. Press 1
Pulmonary Surfactant Proteins Are Inhibited by Immunoglobulin A Autoantibodies in Severe COVID-19
Tobias Sinnberg 1,2,3*, Christa Lichtensteiger 4*, Omar Hasan Ali 4,5,6*, Oltin T. Pop 4, Ann-Kristin Jochum 4,7, Lorenz Risch 8,9,10, Silvio D. Brugger 11, Ana Velic 12, David Bomze 4,13, Philipp Kohler 14, Pietro Vernazza 14, Show All...
Extracellular Vesicle-Encapsulated microRNAs as Novel Biomarkers of Lung Health
Christina M. Eckhardt 1, Simone Gambazza 2,3, Tessa R. Bloomquist 4, Peter De Hoff 5, Aishwarya Vuppala 5, Pantel S. Vokonas 6,7, Augusto A. Litonjua 8, David Sparrow 6,7, Faruque Parvez 4, Louise C. Laurent 5, Joel Schwartz 9, Andrea A. Baccarelli 4, and Haotian Wu 4 ... Show less
Suspected Interstitial Lung Disease in COPDGene Study
Jonathan A. Rose 1, Aravind A. Menon 1, Takuya Hino 2, Akinori Hata 3, Mizuki Nishino 4, David A. Lynch 5, Ivan O. Rosas 6, Souheil El-Chemaly 1, Benjamin A. Raby 7, Samuel Y. Ash 1, Bina Choi 1, George R. Washko 1, Edwin K. Silverman 8, Michael H. Cho 8, Hiroto Hatabu 2, Rachel K. Putman 1*, and Gary M. Hunninghake 1* ... Show less
Validation of Proposed Criteria for Progressive Pulmonary Fibrosis
Janelle Vu Pugashetti 1,2*, Ayodeji Adegunsoye 3*, Zhe Wu 4,5, Cathryn T. Lee 3, Anand Srikrishnan 6, Sahand Ghodrati 2, Vivian Vo 2, Elisabetta A. Renzoni 4,5, Athol U. Wells 4,5, Christine Kim Garcia 7, Felix Chua 4,5, Chad A. Newton 6‡, Philip L. Molyneaux 4,5‡, and Justin M. Oldham 1‡ ... Show less
Risk-stratified Approach for Never- and Ever-Smokers in Lung Cancer Screening: A Prospective Cohort Study in China
Fei Wang 1*, Fengwei Tan 2*, Sipeng Shen 3,4*, Zheng Wu 1*, Wei Cao 1*, Yiwen Yu 1, Xuesi Dong 1, Changfa Xia 1, Wei Tang 5, Yongjie Xu 1, Chao Qin 1, Meng Zhu 3,4, Jibin Li 1, Zhuoyu Yang 1, Yadi Zheng 1, Zilin Luo 1, Liang Zhao 1, Jiang Li 1, Jiansong Ren 1, Jufang Shi 1, Yao Huang 5, Ning Wu 5,6, Hongbing Shen 3,4, Wanqing Chen 1, Ni Li 1,7‡, and Jie He 2‡ ... Show less
Image Phenotyping of Preterm-Born Children Using Hyperpolarized 129Xe Lung Magnetic Resonance Imaging and Multiple-Breath Washout
Ho-Fung Chan 1, Laurie J. Smith 1, Alberto M. Biancardi 1, Jody Bray 1, Helen Marshall 1, Paul J. C. Hughes 1, Guilhem J. Collier 1, Madhwesha Rao 1, Graham Norquay 1, Andrew J. Swift 1, Kylie Hart 2,3, Michael Cousins 2,3, W. John Watkins 2, Jim M. Wild 1, and Sailesh Kotecha 2,3 ... Show less
Nontraumatic Pneumocephalus after Noninvasive Ventilation
Peter J. Edmonds and Melissa A. Warren
Patient Characteristics and Survival for Progressive Pulmonary Fibrosis Using Different Definitions
Yet H. Khor 1,2,3,4*, Malik Farooqi 5, Nathan Hambly 5, Martin Kolb 5, and Christopher J. Ryerson 6,7; for the Austin ILD Registry and CARE-PF Investigators
Antifibrotics and Reduced Mortality in Idiopathic Pulmonary Fibrosis: Immortal Time Bias
Samy Suissa 1,2* and Karine Suissa 3,4
Mechanisms of Obesity-related Asthma: Is Insulin Getting on Your Nerves?
Zhenying Nie *, Allison D. Fryer , David B. Jacoby , and Matthew G. Drake
Impact of Insulin Resistance on Asthma: Is There Truly No Role of “Obesity�?
Dharini M. Bhammar 1*, Tony G. Babb 2, Menglin Xu 1, and Jason H. T. Bates 3
Reply to Nie et al. and Bhammar et al.
Michael C. Peters 1, Mark L. Schiebler 2, David T. Mauger 3, and John V. Fahy
Polymorphisms and Severity of COVID-19
Pathum Sookaromdee 1* and Viroj Wiwanitkit 2,3,4,5,6
Reply to: Sookaromdee and Wiwanitkit
Emily S. Wan 1,2, Anurag Verma 3, Jessica Minnier 4,6, Shiuh-Wen Luoh 4,5*, and Sudha K. Iyengar
